Abacus Life, Inc. (NASDAQ:ABL – Get Free Report) CEO Jay J. Jackson sold 2,031,250 shares of the business’s stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $8.00, for a total transaction of $16,250,000.00. Following the transaction, the chief executive officer now owns 10,562,000 shares of the company’s stock, valued at $84,496,000. This represents a 16.13 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Abacus Life Price Performance
Shares of NASDAQ:ABL traded up $0.12 during midday trading on Monday, reaching $7.67. 676,565 shares of the company’s stock traded hands, compared to its average volume of 78,176. The company has a fifty day simple moving average of $9.30 and a two-hundred day simple moving average of $9.81. Abacus Life, Inc. has a 1 year low of $6.56 and a 1 year high of $13.25. The company has a market cap of $572.57 million, a P/E ratio of -42.61 and a beta of 0.15. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.29 and a current ratio of 1.29.
Abacus Life (NASDAQ:ABL – Get Free Report) last posted its quarterly earnings data on Thursday, November 7th. The company reported $0.20 earnings per share for the quarter, topping analysts’ consensus estimates of $0.14 by $0.06. Abacus Life had a negative net margin of 11.65% and a positive return on equity of 12.88%. The company had revenue of $28.15 million during the quarter, compared to analysts’ expectations of $26.08 million. During the same period in the prior year, the business posted $0.01 earnings per share. Equities analysts predict that Abacus Life, Inc. will post 0.62 EPS for the current fiscal year.
Institutional Inflows and Outflows
Analyst Ratings Changes
Several equities analysts have recently issued reports on ABL shares. Northland Securities initiated coverage on Abacus Life in a report on Thursday, October 24th. They issued an “outperform” rating and a $13.50 price objective for the company. Northland Capmk raised Abacus Life to a “strong-buy” rating in a report on Thursday, October 24th. Piper Sandler reaffirmed an “overweight” rating and set a $13.00 price objective (up previously from $12.00) on shares of Abacus Life in a research note on Friday, November 8th. TD Cowen assumed coverage on shares of Abacus Life in a research note on Wednesday, August 7th. They issued a “buy” rating and a $14.00 target price for the company. Finally, B. Riley raised their price target on shares of Abacus Life from $16.00 to $17.00 and gave the company a “buy” rating in a research report on Monday. Five equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $14.70.
Get Our Latest Research Report on ABL
Abacus Life Company Profile
Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.
Recommended Stories
- Five stocks we like better than Abacus Life
- What Are Dividends? Buy the Best Dividend Stocks
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- 5 Top Rated Dividend Stocks to Consider
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- Are Penny Stocks a Good Fit for Your Portfolio?
- Discover the 3 Best Performing Stocks That Went Public in 2024
Receive News & Ratings for Abacus Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abacus Life and related companies with MarketBeat.com's FREE daily email newsletter.